GLP-1s reduce systemic inflammation, a key driver of aging, with measurable improvements in immune and metabolic markers
8 Division of Endocrinology & Metabolism, Department of Medicine, 9 Division of Infectious Diseases, Department of Medicine, and 10 Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada
Tahamtan A, Ardebili A
It's designed for ongoing use and provides blood glucose control and cardiovascular benefits
Key Takeaways Preclinical data on BPC-157 are promising across musculoskeletal and GI models, but human trials are sparse
If you see particles floating in solution after mixing, the peptide has degraded or precipitated